vimarsana.com
Home
Live Updates
Scenario 1: A 47-Year-Old Man With Intermediate Risk Metasta
Scenario 1: A 47-Year-Old Man With Intermediate Risk Metasta
Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC
Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.
Related Keywords
,
Optimizing Outcomes ,
Patients With ,
Translating Evidence ,
Clinical Practice ,
Year Old Man With Intermediate Risk Metastatic ,
Renal Cell Carcinoma ,
Nrcc ,
Kidney Cancer ,
Metastatic Rcc ,
Metastatic Kidney Cancer ,
Advanced Rcc ,
Advanced Kidney Cancer ,
Nivolumab ,
Ipilimumab ,
Ipi Nivo ,
Nivo Ipi ,
Trio Therapy ,
Immune Checkpoint Inhibitors ,
Prednisone ,
Liver Resection ,
Left Radical Nephrectomy ,
Consolidation Therapy ,
Combination Therapy ,
Novel Therapy ,